Myofascial Pain Syndrome and Plantar Fasciitis Treatment

Study Overview
=================
Brief Summary
-----------------
Patients with plantar fasciitis between the ages of 25-65 years who presented to the Physical Medicine and Rehabilitation clinic with the complaint of heel pain and met the inclusion and exclusion criteria will be included in the study. Demographic data (age, gender, body mass index, symptom duration) will be recorded at the beginning of the study. Then, Foot Functional Index (FFI) and Visual Analog Scale (VAS) scales will be recorded. Participants will be randomly divided into two groups. Group 1 will receive dry needling and Group 2 will receive extracorporeal shock wave therapy (ESWT). Patients in the 1st group will undergo 3 sessions of dry needling with Seirin branded 0.6*50 mm acupuncture needles at one week intervals for the trigger point detected by manual palpation in the medial gastrocnemius, lateral gastrocnemius, soleus, flexor digitorum brevis, quadratus plantae, abductor hallucis brevis muscles. Patients in the 2nd group, Patients in this group received three sessions of ESWT (MASTERPLUS MP 200 ENERGY 2 trademarked ESWT device) at an energy density of 2 bars and a frequency of 2,000 shocks/min at 12 Hz for three weeks, each session once a week. Each of the five most sensitive and painful points was given 400 pulses in the supine position

Official Title
-----------------
Myofascial Pain Syndrome in Plantar Fasciitis; Comparison of Dry Needling and Extracorporeal Shockwave Therapy (ESWT) Effects on Pain and Function

Conditions
-----------------
Plantar Fascitis, Myofascial Pain Syndrome

Intervention / Treatment
-----------------
* Device: ESWT
* Procedure: Dry needling


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients aged 25-65 years with heel pain for more than 6 weeks tenderness on palpation in the medial calcaneal region aggravation of symptoms while standing and in the first hours of the morning who agreed not to receive anti-inflammatory treatment during the study period fascia thickness >4mm measured by ultrasound. Exclusion Criteria: Patients diagnosed with rheumatologic diseases Those diagnosed with Diabetes Mellitus (DM), those with chronic liver and kidney failure Anti-inflammatory-analgesic treatment within the last 1 month Diagnosed with inflammatory rheumatic disease Those with a history of foot surgery Those with mid or hindfoot deformity Previous history of central or peripheral nerve damage, lower extremity neuropathy Those diagnosed with Diabetes Mellitus Those with cognitive impairment Unassisted mobilization Those with bleeding disorders Pregnant women

Ages Eligible for Study
-----------------
Minimum Age: 25 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: Participants will be randomly divided into 2 groups and will be treated with ESWT or Dry needling.
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: group 1: ESWT treatment<br>Participants in this group will only receive ESWT treatment | Device: ESWT<br>* Patients in this group received three sessions of ESWT (MASTERPLUS MP 200 ENERGY 2 trademarked ESWT device) at an energy density of 2 bars and a frequency of 2,000 shocks/min at 12 Hz for three weeks, each session once a week. Each of the five most sensitive and painful points was given 400 pulses in the supine position<br>|
| Active Comparator: Dry needling<br>Participants in this group will only receive Dry needling treatment | Procedure: Dry needling<br>* Dry needling with Seirin branded 0.6*50 mm acupuncture needles will be performed for 3 sessions with one week intervals for the trigger point detected by manual palpation in the medial gastrocnemius, lateral gastrocnemius, soleus, flexor digitorum brevis, quadratus plantae, abductor hallucis brevis muscles of the patients in the group.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Pain was evaluated with a Visual analog scale (VAS) score. | VAS score ranges from 0 to 10. Comparison of the effects of ESWT and dry needling on pain in the management of plantar fasciitis | 5 months | 
| Function was evaluated with (Foot Functional Index) FFI score. | Comparison of the effects of ESWT and dry needling on function in the management of plantar fasciitis | 5 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
plantar fasciitis, ESWT, dry needling